Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2009 Nov 23;27(50):7110-5. doi: 10.1016/j.vaccine.2009.09.056. Epub 2009 Sep 26.

The timing of influenza vaccination for older adults (65 years and older).

Author information

1
Section of Decision Sciences and Clinical Systems Modeling, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA. BYL1@pitt.edu

Abstract

While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (< or =$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

PMID:
19786135
PMCID:
PMC2783217
DOI:
10.1016/j.vaccine.2009.09.056
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center